We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+113.09%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$452M
AUM Growth
+$130M
Cap. Flow
-$18.5M
Cap. Flow %
-4.08%
Top 10 Hldgs %
10.66%
Holding
352
New
147
Increased
15
Reduced
84
Closed
97

Top Buys

Rank Stock Value
1
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$3.03M
2
OSPN icon
OneSpan
OSPN
+$2.96M
3
ATEX icon
Anterix
ATEX
+$2.79M
4
CALX icon
Calix
CALX
+$2.73M
5
GNMK
GenMark Diagnostics, Inc
GNMK
+$2.72M

Top Sells

Rank Stock Value
1
AXSM icon
Axsome Therapeutics
AXSM
+$3.54M
2
KPTI icon
Karyopharm Therapeutics
KPTI
+$3.44M
3
TDOC icon
Teladoc Health
TDOC
+$3.2M
4
KRYS icon
Krystal Biotech
KRYS
+$3M
5
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$2.95M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 21.89%
3 Consumer Discretionary 16.2%
4 Industrials 10.05%
5 Consumer Staples 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
151
Iovance Biotherapeutics
IOVA
$1.94B
$1.46M 0.32%
53,143
-18,629
-26% -$612K
QDEL icon
152
QuidelOrtho
QDEL
$1.19B
$1.45M 0.32%
6,482
-11,268
-63% -$1.77M
PENN icon
153
PENN Entertainment
PENN
$2.63B
$1.44M 0.32%
+47,277
New +$1.08M
STMP
154
DELISTED
Stamps.com, Inc.
STMP
$1.43M 0.32%
+7,771
New +$1.33M
REPL icon
155
Replimune Group
REPL
$994M
$1.42M 0.31%
+57,086
New +$1.01M
SMCI icon
156
Super Micro Computer
SMCI
$19.6B
$1.41M 0.31%
+497,120
New +$1.25M
CERS icon
157
Cerus
CERS
$457M
$1.4M 0.31%
+212,520
New +$1.22M
NMIH icon
158
NMI Holdings
NMIH
$3.38B
$1.39M 0.31%
+86,702
New +$1.23M
TDOC icon
159
Teladoc Health
TDOC
$1.26B
$1.39M 0.31%
7,283
-18,285
-72% -$3.2M
UTI icon
160
Universal Technical Institute
UTI
$2.33B
$1.38M 0.3%
198,350
-231,902
-54% -$1.52M
RGEN icon
161
Repligen
RGEN
$8.95B
$1.37M 0.3%
11,099
-12,160
-52% -$1.43M
OVID icon
162
Ovid Therapeutics
OVID
$489M
$1.36M 0.3%
184,728
– –
ENTG icon
163
Entegris
ENTG
$22.2B
$1.32M 0.29%
22,417
-9,260
-29% -$514K
PZZA icon
164
Papa John's
PZZA
$979M
$1.31M 0.29%
16,524
-5,612
-25% -$417K
CRL icon
165
Charles River Laboratories
CRL
$12.6B
$1.31M 0.29%
7,501
-4,545
-38% -$725K
PEGA icon
166
Pegasystems
PEGA
$5.23B
$1.28M 0.28%
25,246
-20,564
-45% -$891K
CZR icon
167
Caesars Entertainment
CZR
$6.13B
$1.25M 0.28%
+31,270
New +$867K
TBCH
168
Turtle Beach Corp
TBCH
$269M
$1.25M 0.28%
+84,858
New +$875K
CEVA icon
169
CEVA Inc
CEVA
$954M
$1.25M 0.28%
33,359
-13,017
-28% -$417K
MRTN icon
170
Marten Transport
MRTN
$1.22B
$1.24M 0.27%
+74,001
New +$1.16M
GNOG
171
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
$1.23M 0.27%
+75,044
New +$763K
CCLD icon
172
CareCloud
CCLD
$108M
$1.22M 0.27%
146,792
– –
POWI icon
173
Power Integrations
POWI
$3.45B
$1.22M 0.27%
20,598
-9,740
-32% -$512K
RHP icon
174
Ryman Hospitality Properties
RHP
$8.05B
$1.22M 0.27%
+35,113
New +$1.17M
MHH icon
175
Mastech Digital
MHH
$94.4M
$1.2M 0.27%
46,316
-47,155
-50% -$836K
5 6
7
8 9

Similar funds

RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
ICCFIA
IDG China Capital Fund III Associates Central Hong Kong, China $868M AUM 24.3% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
WCM
Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

EAM Investors's Q2 2020 Portfolio in Review

As of Q2 2020, EAM Investors held 352 positions worth $452M, up 40% from $322M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $18.5M in Q2 2020, closing 97 positions and reducing 84 holdings. Its most notable exit was Karyopharm Therapeutics, an estimated $3.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 40% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Investors opened a new position in Aspira Women's Health Inc. Common Stock worth $2.61M.

  • EAM Investors's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 45,313 shares worth $2.61M.
  • EAM Investors added most to Purple Innovation in Q2 2020, an estimated $2.04M increase.
  • EAM Investors's biggest Q2 2020 reduction was Axsome Therapeutics, cutting an estimated $3.54M.
  • EAM Investors fully exited Karyopharm Therapeutics in Q2 2020, selling an estimated $3.44M.
  • EAM Investors's ten largest holdings make up 11% of its $452M portfolio in Q2 2020.
  • EAM Investors opened 147 new positions and closed 97 in Q2 2020.
  • EAM Investors's portfolio value rose 40% quarter-over-quarter to $452M.

Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.